Voiding dysfunction requiring therapy affects a significant proportion of older patients treated for NMIBC. Voiding dysfunction affects approximately 1 in 6 older patients treated for ...
Noninvasive treatment options for NGB dysfunction include intermittent catheterization, Crede and Valsalva, indwelling catheterization, lifestyle changes/behavioral modification, and oral ...
Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive bladder market.
Little research has been published to guide practice in DC management. Evidence is modest at best for all interventions except glycemic control. Preventing further diabetes-associated neuropathy is an ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
Editor’s note: Startup Spotlight is a regular part of TechWire’s Startup Monday lineup. RESEARCH TRIANGLE PARK – Dignify Therapeutics, a pharmaceutical and medical device development company in ...
If you're like most people, you probably don't give much thought to your bladder or bowel function unless something goes wrong. Unfortunately, though, these types of dysfunctions are common among ...
The first successful human bladder transplant could offer hope for people with bladder problems. On May 4, 2025, Oscar Larrainzar, 41, became the first human to successfully receive a bladder ...
The underactive bladder syndrome market is expected to grow steadily, driven by an aging global population and rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results